Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)-MedSci.cn

Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)

Morris, M; Vogelzang, NJ; Sartor, O; Armour, A; Groaning, M; Messmann, R; Robarts, A; Petrylak, DP; Tolcher, A; Gordon, MS; Babiker, H

ANNALS OF ONCOLOGY, 2017; 28 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务